Paper28484
Synthetic alpha-adrenergic agonists are potent alpha-adrenergic blockers in human platelets.
Jakobs KH. Nature, 1978. Cited by 65 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Synthetic alpha-adrenergic agonists are potent alpha-adrenergic blockers in human platelets. Papers, record 28484. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28484
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Synthetic alpha-adrenergic agonists are potent alpha-adrenergic blockers in human platelets.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adrenergic alpha-Agonists | Major topic |
| Adrenergic alpha-Antagonists | Major topic |
| Platelet Aggregation | Major topic |
| Adenylyl Cyclases | |
| Blood Platelets | |
| Humans | |
| Receptors, Adrenergic, alpha |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 65 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6,407,043 | 3H-Rauwolscine binding in platelets from depressed patients and healthy volunteers. | Psychopharmacology (Berl) | 1983 | https://conductscience.org/library/papers/6407043 | PubMed |
| 6,309,647 | Genetic control of adrenergic receptors on human platelets. A twin study. | Hum Genet | 1983 | https://conductscience.org/library/papers/6309647 | PubMed |
| 6,270,654 | Solubilization of human platelet alpha-adrenergic receptors: evidence that agonist occupancy of the receptor stabilizes receptor--effector interactions. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6270654 | PubMed |
| 6,268,994 | Stimulation of prostaglandin E2-synthesis by noradrenaline in primary cell cultures from rabbit splenic pulpa is mediated by atypical alpha-adrenoceptors. | Naunyn Schmiedebergs Arch Pharmacol | 1981 | https://conductscience.org/library/papers/6268994 | PubMed |
| 6,145,472 | Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets. | Br J Pharmacol | 1984 | https://conductscience.org/library/papers/6145472 | PubMed |
| 6,121,295 | Alpha 2-adrenoceptors inhibit the cholera-toxin-induced intestinal fluid accumulation. | Naunyn Schmiedebergs Arch Pharmacol | 1982 | https://conductscience.org/library/papers/6121295 | PubMed |
| 6,110,451 | Interaction of selective alpha-adrenoceptor agonists and antagonists with human and rabbit blood platelets. | Br J Pharmacol | 1980 | https://conductscience.org/library/papers/6110451 | PubMed |
| 41,192 | Alpha adrenoceptors in rat brain: direct identification with prazosin. | Naunyn Schmiedebergs Arch Pharmacol | 1979 | https://conductscience.org/library/papers/41192 | PubMed |
| 36,571 | Agonistic and antagonistic effects of various alpha-adrenergic agonists in human platelets. | Naunyn Schmiedebergs Arch Pharmacol | 1979 | https://conductscience.org/library/papers/36571 | PubMed |
| 34,106 | Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation. | Nature | 1979 | https://conductscience.org/library/papers/34106 | PubMed |
| 32,430 | [3H] Dihydroergonine binding to alpha-adrenergic receptors in human platelets. | Klin Wochenschr | 1978 | https://conductscience.org/library/papers/32430 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28484
GET https://conductscience.org/api/papers/v1/28484/authors